AI assistant
Amoéba — Regulatory Filings 2016
Nov 21, 2016
1107_iss_2016-11-21_fd0feb9a-66dc-4588-88e1-69b2ccdb9c4e.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
FOR IMMEDIATE RELEASE
AMOEBA ANNOUNCES RECEIPT OF THE FIRST DRAFT OF THE REGULATORY EVALUATION REPORT
Lyon, 21st November 2016 - AMOEBA (FR0011051598 - AMEBA), the producer of a biological biocide capable of eliminating the risk of waterborne bacteria, has announced today that it has received the first draft of the evaluation report (first draft Competent Authority Report) for the active substance of the BIOMEBA biocide, Willaertia magna C2c Maky.
In accordance with the regulatory procedure, the company has until 14th December 2016 to submit its comments to the French regulatory authority on biocidal products, ANSES.
AMOEBA has all the elements to comment on the conclusions of this first draft and will send both its comments and clarifications within the deadline.
The company will have to wait for the final report, including the consolidation of the first draft and all the comments submitted by AMOEBA, before submitting its request for provisional marketing authorisation for the BIOMEBA biocide.
« This is an important step for AMOEBA. Our regulatory and scientific teams already hold all the data to submit their comments. We will supply all the required information by 14th December 2016", stated Fabrice PLASSON, President of AMOEBA's Board of Directors.
About AMOEBA: AMOEBA develops a biological biocide capable of eliminating waterborne bacterial risk (legionella, pseudomonas, listeria, etc.). This entirely natural solution is presented as an alternative to the chemical treatments traditionally used in the industrial sector and complies with the new regulations in terms of chemical emissions into the environment. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1) , AMOEBA is today concentrating on the segment of industrial air-cooled towers (ACT), estimated to be worth EUR 1.7bn (2) . AMOEBA is pursuing the regulatory procedures to obtain the provisional MA for all European countries in "Cooling Towers" application. Based in Chassieu – France. AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index. For more information: www.amoeba-biocide.com.
(1) : Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets (2) : Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013
Contacts :
| Amoéba | Actifin |
|---|---|
| Nathalie COMBROUSSE | Ghislaine GASPARETTO |
| Responsable Marketing Communication | Communication financière |
| Tel : +33 (0)4 81 09 18 15 | Tel : +33 (0)1 56 88 11 11 |
| [email protected] | [email protected] |